Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genentech IncfiledCriticalGenentech Inc
Publication of AR114997A2publicationCriticalpatent/AR114997A2/en
La presente hace referencia a anticuerpos anti-factor D, sus secuencias de aminoácidos y ácidos nucleicos, las células y vectores que contienen estos anticuerpos y su producción y uso en la preparación de composiciones y medicamentos para el tratamiento de enfermedades y trastornos asociados a una activación excesiva o descontrolada del complemento. Estos anticuerpos son útiles para diagnóstico, prevención y tratamiento de enfermedades.This refers to anti-factor D antibodies, their amino acid and nucleic acid sequences, the cells and vectors that contain these antibodies and their production and use in the preparation of compositions and medicaments for the treatment of diseases and disorders associated with activation. excessive or uncontrolled complement. These antibodies are useful for the diagnosis, prevention and treatment of diseases.
ARP180103880A2008-04-282018-12-27
HUMANIZED ANTI-FACTOR D ANTIBODIES AND THEIR USES
AR114997A2
(en)